Lepage, Christian
Muehlmann, Marc
Tripodis, Yorghos
Hufschmidt, Jakob
Stamm, Julie
Green, Katie
Wrobel, Pawel
Schultz, Vivian
Weir, Isabelle
Alosco, Michael L.
Baugh, Christine M.
Fritts, Nathan G.
Martin, Brett M.
Chaisson, Christine
Coleman, Michael J.
Lin, Alexander P.
Pasternak, Ofer
Makris, Nikos
Stern, Robert A.
Shenton, Martha E.
Koerte, Inga K. https://orcid.org/0000-0003-1281-9286
Funding for this research was provided by:
National Institutes of Health (R01 NS 078337, F31 NS 081957, 1F32NS096803-01, P30 AG13846, UL1-TR000157, P41 EB015902, T32GM074905)
Article History
First Online: 19 May 2018
Compliance with ethical standards
: All procedures performed in this study were in accordance with the ethical standards of the Boston University Medical Campus Institutional Review Board, the Partners Institutional Review Board, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: For all other authors, no competing financial interests exist.Dr. Robert Stern is a paid consultant to Avanir Pharmaceuticals, Inc. (Aliso Viejo, CA), Biogen (Cambridge, MA), and Eli Lilly (Indianapolis, IN). He receives royalties for published neuropsychological tests from Psychological Assessment Resources, Inc. (Lutz, FL, USA).
: Informed consent was obtained from all individual participants included in the study.